Related references
Note: Only part of the references are listed.Adversity Considerations for Thyroid Follicular Cell Hypertrophy and Hyperplasia in Nonclinical Toxicity Studies: Results From the 6th ESTP International Expert Workshop
Maike Huisinga et al.
TOXICOLOGIC PATHOLOGY (2020)
Carcinogenicity of isobutyl nitrite, β-picoline, and some acrylates
Hans Kromhout et al.
LANCET ONCOLOGY (2018)
An Adverse Outcome Pathway (AOP) for forestomach tumors induced by non-genotoxic initiating events
Deborah M. Proctor et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
The role of ethyl acrylate induced GSH depletion in the rodent forestomach and its impact on MTD and in vivo genotoxicity in developing an adverse outcome pathway (AOP)
R. Ellis-Hutchings et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
Assessment of the mode of action underlying development of forestomach tumors in rodents following oral exposure to ethyl acrylate and relevance to humans
Chad M. Thompson et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
A review of the genotoxic, mutagenic, and carcinogenic potentials of several lower acrylates
Mina Suh et al.
TOXICOLOGY (2018)
Human relevance of follicular thyroid tumors in rodents caused by non-genotoxic substances
Ruediger Bartsch et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
Alcohol Metabolism
Arthur I. Cederbaum
CLINICS IN LIVER DISEASE (2012)
Comparison of NTP Historical Control Tumor Incidence Rates in Female Harlan Sprague Dawley and Fischer 344/N Rats
Gregg E. Dinse et al.
TOXICOLOGIC PATHOLOGY (2010)
Evaluation of potential human carcinogenicity of the synthetic monomer ethyl acrylate
Gary M. Williams et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Share Paper
